// June 26, 2023
Complex generics: Are global regulators addressing the needs?
The development of generic versions of innovator medicines is a global public health need.
The development of generic versions of innovator medicines is a global public health need.
USP was founded nearly 200 years ago by eleven doctors who wanted to ensure that the nation had a
The opioid crisis in the U.S.
By Luc Besançon, Pharm.D. | Chief Executive Officer, International